Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
Main Authors: | Ai Kuwahara, Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Kazuhiko Nakao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12351 |
Similar Items
-
Transhepatic embolization of a congenital intrahepatic portosystemic shunt for the treatment of hepatic encephalopathy in a noncirrhotic patient using Amplatzer vascular plug device
by: Rachel Ann Brader, BS, et al.
Published: (2017-06-01) -
Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
by: Fumika Azuma, et al.
Published: (2021-11-01) -
Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options
by: Philips CA, et al.
Published: (2019-01-01) -
Portosystemic Encephalopathy in a Noncirrhotic Patient Treated by Vascular Plug Embolization of Mesoiliac Shunt
by: Othman Alshehre, et al.
Published: (2020-01-01) -
Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy
by: Brandon Toliver, et al.